Literature DB >> 25505362

FASTING PLASMA LIPID, GLUCOSE, AND INSULIN LEVELS IN PRADER-WILLI SYNDROME AND OBESE INDIVIDUALS.

Merlin G Butler1, Larry L Swift1, James O Hill1.   

Abstract

Plasma lipid, glucose, and insulin levels were measured from 26 patients with Prader-Willi syndrome (16 with the chromosome 15q deletion and 10 with normal chromosomes) and 32 obese, normal individuals. The average percentage of ideal body weight (IBW) for the former group was 175.6 ± 68.0, compared to 150.3 ± 43.8 for the latter. Fasting plasma lipid, glucose, and insulin levels were not significantly different between the two groups. No significant correlations were found among the three measurements in patients with PWS (deletion or nondeletion) or obese individuals and either age or percentage of IBW. Both insulin and glucose levels were higher in the PWS group, while only insulin levels were higher in the obese group compared with normative laboratory standards. Our study supports previously reported lipid, glucose, and insulin data in PWS and obesity.

Entities:  

Keywords:  glucose; insulin; lipids; obesity

Year:  1990        PMID: 25505362      PMCID: PMC4258708     

Source DB:  PubMed          Journal:  Dysmorphol Clin Genet        ISSN: 0893-6633


  9 in total

1.  Characterization of Obesity in the Prader-Labhart-Willi Syndrome: Fatness Patterning.

Authors:  F John Meaney; Merlin G Butler
Journal:  Med Anthropol Q       Date:  2009-10-28

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Hypotonia, mental retardation, obesity, and cryptorchidism associated with dwarfism and diabetes in children.

Authors:  B M Laurance
Journal:  Arch Dis Child       Date:  1967-04       Impact factor: 3.791

4.  Immunoreactive insulin and growth hormone responses in patients with Prader-Willi syndrome.

Authors:  A Parra; C Cervantes; R B Schultz
Journal:  J Pediatr       Date:  1973-10       Impact factor: 4.406

5.  Blood lipids in children with the Prader-Willi syndrome. A comparison with simple obesity.

Authors:  C G Theodoridis; E C Albutt; G W Chance
Journal:  Aust Paediatr J       Date:  1971-03

6.  Energy expenditure and body composition in Prader-Willi syndrome.

Authors:  D A Schoeller; L L Levitsky; L G Bandini; W W Dietz; A Walczak
Journal:  Metabolism       Date:  1988-02       Impact factor: 8.694

7.  Serum insulin-releasing activity and the Prader-Willi syndrome.

Authors:  P Lautala; M Knip; H K Akerblom; K Kouvalainen; J M Martin
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1986

8.  Prader-Willi syndrome: current understanding of cause and diagnosis.

Authors:  M G Butler
Journal:  Am J Med Genet       Date:  1990-03

9.  A reduced number of insulin receptors in patients with Prader-Willi syndrome.

Authors:  A M Kousholt; H Beck-Nielsen; H T Lund
Journal:  Acta Endocrinol (Copenh)       Date:  1983-11
  9 in total
  5 in total

1.  Sleeve gastrectomy leads to weight loss in the Magel2 knockout mouse.

Authors:  Deanna M Arble; Joshua W Pressler; Joyce Sorrell; Rachel Wevrick; Darleen A Sandoval
Journal:  Surg Obes Relat Dis       Date:  2016-04-27       Impact factor: 4.734

Review 2.  Prader-Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach.

Authors:  Silvia Savastano; Giovanna Muscogiuri; Luigi Barrea; Claudia Vetrani; Danilo Fintini; Giulia de Alteriis; Filippo Maria Panfili; Sarah Bocchini; Ludovica Verde; Annamaria Colao
Journal:  Curr Obes Rep       Date:  2022-09-05

3.  Prader-Willi syndrome: current understanding of cause and diagnosis.

Authors:  M G Butler
Journal:  Am J Med Genet       Date:  1990-03

Review 4.  Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.

Authors:  G Muscogiuri; L Barrea; F Faggiano; M I Maiorino; M Parrillo; G Pugliese; R M Ruggeri; E Scarano; S Savastano; A Colao
Journal:  J Endocrinol Invest       Date:  2021-04-23       Impact factor: 4.256

Review 5.  Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.

Authors:  Felipe Correa-da-Silva; Eric Fliers; Dick F Swaab; Chun-Xia Yi
Journal:  J Neuroendocrinol       Date:  2021-06-22       Impact factor: 3.627

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.